At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient ...
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...
Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...
President-elect Donald Trump’s proposed tariffs on good from Canada, Mexico and China could raise costs, disrupt supply ...
The venture firm Vensana Capital has raised its third medtech-focused fund in the past six years, with $425 million in new ...
Industry experts expect that the Central Drugs Standard Control Organisation (CDSCO) could reclassify more medical devices ...
It’s incredibly rewarding to build in the medtech space, but some data suggests the average medical device requires $31 ...
Venture capital firm Vensana Capital, headquartered in Minneapolis, has closed a $425 million fund to further fuel medtech startups, some of which are in the Twin Cities. Founded in 2019, Vensana ...
J.P. Morgan has once again picked Boston Scientific (NYSE:BSX) and Intuitive Surgical (NASDAQ:ISRG) as its top large-cap ...
Last December, the FDA published its final guidance on predetermined change control plans, or PCCPs, with recommendations to ...
Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...